Karapanou O - Search Results

1

Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence.

Karapanou O, Tzanela M, Rondogianni P, Dacou-Voutetakis C, Chiotis D, Vlassopoulou B, Vassiliadi D, Kanaka-Gantenbein C, Tsagarakis S. Karapanou O, et al. Endocrine. 2020 Dec;70(3):566-574. doi: 10.1007/s12020-020-02378-2. Epub 2020 Jun 13. Endocrine. 2020. PMID: 32533509

2

Differentiated thyroid cancer in childhood: a literature update.

Karapanou O, Tzanela M, Vlassopoulou B, Kanaka-Gantenbein C. Karapanou O, et al. Hormones (Athens). 2017 Oct;16(4):381-387. doi: 10.14310/horm.2002.1758. Hormones (Athens). 2017. PMID: 29518758 Free article. Review.

3

Histology is more ιmportant than persistent anti-Tg antibodies for progression of differentiated thyroid cancer.

Karapanou O, Saltiki K, Simeakis G, Botoula E, Tsagarakis S, Alevizaki M, Vlassopoulou B. Karapanou O, et al. Clin Endocrinol (Oxf). 2021 Jul;95(1):217-223. doi: 10.1111/cen.14456. Epub 2021 Mar 21. Clin Endocrinol (Oxf). 2021. PMID: 33682167

4

Medical therapy for non-functioning pituitary tumors-a critical approach.

Tampourlou M, Karapanou O, Vassiliadi DA, Tsagarakis S. Tampourlou M, et al. Among authors: karapanou o. Hormones (Athens). 2019 Jun;18(2):117-126. doi: 10.1007/s42000-018-0070-0. Epub 2018 Oct 27. Hormones (Athens). 2019. PMID: 30368687 Review.

5

Advanced RAI-refractory thyroid cancer: an update on treatment perspectives.

Karapanou O, Simeakis G, Vlassopoulou B, Alevizaki M, Saltiki K. Karapanou O, et al. Endocr Relat Cancer. 2022 Apr 22;29(5):R57-R66. doi: 10.1530/ERC-22-0006. Endocr Relat Cancer. 2022. PMID: 35266878 Review.

6

Health status of Greek thyroid cancer patients after radioiodine administration compared to a demographically matched general population sample.

Karapanou O, Papadopoulos A, Vlassopoulou B, Vassilopoulos C, Pappa E, Tsagarakis S, Niakas D. Karapanou O, et al. Hell J Nucl Med. 2012 May-Aug;15(2):98-102. doi: 10.1967/s002449910028. Epub 2012 Jun 27. Hell J Nucl Med. 2012. PMID: 22741146

7

Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option?

Karapanou O, Vlassopoulou B, Tzanela M, Stratigou T, Tsatlidis V, Tsirona S, Tsagarakis S. Karapanou O, et al. Endocr Pract. 2013 May-Jun;19(3):e77-82. doi: 10.4158/EP12346.CR. Endocr Pract. 2013. PMID: 23425648

8

Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.

Perogamvros I, Vassiliadi DA, Karapanou O, Botoula E, Tzanela M, Tsagarakis S. Perogamvros I, et al. Among authors: karapanou o. Eur J Endocrinol. 2015 Dec;173(6):719-25. doi: 10.1530/EJE-15-0566. Epub 2015 Sep 1. Eur J Endocrinol. 2015. PMID: 26330465

9

Gonadotroph pituitary macroadenoma inducing ovarian hyperstimulation syndrome: successful response to octreotide therapy.

Karapanou O, Tzanela M, Tamouridis N, Tsagarakis S. Karapanou O, et al. Hormones (Athens). 2012 Apr-Jun;11(2):199-202. doi: 10.14310/horm.2002.1347. Hormones (Athens). 2012. PMID: 22801566 Free article.

10

X-linked adrenoleukodystrophy: are signs of hypogonadism always due to testicular failure?

Karapanou O, Vlassopoulou B, Tzanela M, Papadopoulos D, Angelidakis P, Michelakakis H, Ioannidis G, Mihalatos M, Kamakari S, Tsagarakis S. Karapanou O, et al. Hormones (Athens). 2014 Jan-Mar;13(1):146-52. doi: 10.1007/BF03401330. Hormones (Athens). 2014. PMID: 24722136 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page